PIRTOBRUTINIB

Clinical trials for PIRTOBRUTINIB explained in plain language.

Never miss a new study

Get alerted when new PIRTOBRUTINIB trials appear

Sign up with your email to follow new studies for PIRTOBRUTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2

New hope for brain cancer: Triple-Drug attack shows promise

Disease control Recruiting now

This study tests a combination of three drugs (thiotepa, pirtobrutinib, and sintilimab) for people with a type of brain lymphoma that has come back or is hard to treat. The goal is to see if this mix can shrink tumors and help patients live longer. About 24 adults will take part,…

Matched conditions: PIRTOBRUTINIB

Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control

Last updated Jun 27, 2026 09:06 UTC

PIRTOBRUTINIB

Get alerted when new PIRTOBRUTINIB trials appear

New hope for brain cancer: Triple-Drug attack shows promise